Tumor microenvironment and immune escape

被引:137
作者
Ferrone, Soldano [1 ]
Whiteside, Theresa L. [1 ]
机构
[1] Univ Pittsburgh, Hillman Canc Ctr, Inst Canc, Pittsburgh, PA 15213 USA
关键词
D O I
10.1016/j.soc.2007.08.004
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
This article describes the multiple escape mechanisms used by tumor cells to avoid T-cell-mediated recognition and destruction. The discussion focuses on escape mechanisms that may result from changes at the level of TA-specific cytotoxic T lymphocytes and tumor cells in the tumor microenvironment. Specifically, we discuss the negative impact of regulatory T cells and T-cell apoptosis on the tumor antigen-specific cytotoxic T lymphocyte response. We also discuss changes in the expression of histocompatibility antigens by tumor cells, which may affect tumor cell-immune cell interactions.
引用
收藏
页码:755 / +
页数:21
相关论文
共 115 条
[1]
Alterations in the T-Cell receptor variable gene-restricted profile of CD8+ T lymphocytes in the peripheral circulation of patients with squamous cell carcinoma of the head and neck [J].
Albers, AE ;
Visus, C ;
Tsukishiro, T ;
Ferris, RL ;
Gooding, W ;
Whiteside, TL ;
De Leo, AB .
CLINICAL CANCER RESEARCH, 2006, 12 (08) :2394-2403
[2]
Immune responses to p53 in patients with cancer:enrichment in tetramer+p53 peptide-specific T cells and regulatory T cells at tumor sites [J].
Albers, AE ;
Ferris, RL ;
Kim, GG ;
Chikamatsu, K ;
DeLeo, AB ;
Whiteside, TL .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2005, 54 (11) :1072-1081
[3]
Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production [J].
Allan, Sarah E. ;
Crome, Sarah Q. ;
Crellin, Natasha K. ;
Passerini, Laura ;
Steiner, Theodore S. ;
Bacchetta, Rosa ;
Roncarolo, Maria G. ;
Levings, Megan K. .
INTERNATIONAL IMMUNOLOGY, 2007, 19 (04) :345-354
[4]
T cell expansion: The Survivin interface between cell proliferation and cell death [J].
Altieri, DC .
IMMUNITY, 2005, 22 (05) :534-535
[5]
Inability of a fusion protein of IL-2 and diphtheria toxin (Denileukin Diftitox, DAB389IL-2, ONTAK) to eliminate regulatory T lymphocytes in patients with melanoma [J].
Attia, P ;
Maker, AV ;
Haworth, LR ;
Rogers-Freezer, L ;
Rosenberg, SA .
JOURNAL OF IMMUNOTHERAPY, 2005, 28 (06) :582-592
[6]
Regulatory T cells in ovarian cancer: Biology and therapeutic potential [J].
Barnett, B ;
Kryczek, I ;
Cheng, P ;
Zou, WP ;
Curiel, TJ .
AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2005, 54 (06) :369-377
[7]
Rapamycin promotes expansion of functional CD4+CD25+FOXP3+ regulatory T cells of both healthy subjects and type 1 diabetic patients [J].
Battaglia, Manuela ;
Stabilini, Angela ;
Migliavacca, Barbara ;
Horejs-Hoeck, Jutta ;
Kaupper, Thomas ;
Roncarolo, Maria-Grazia .
JOURNAL OF IMMUNOLOGY, 2006, 177 (12) :8338-8347
[8]
IL-15 promotes the survival of naive and memory phenotype CD8+ T cells [J].
Berard, M ;
Brandt, K ;
Paus, SB ;
Tough, DF .
JOURNAL OF IMMUNOLOGY, 2003, 170 (10) :5018-5026
[9]
Expansion and characteristics of human T regulatory type 1 cells in co-cultures simulating tumor microenvironment [J].
Bergmann, Christoph ;
Strauss, Laura ;
Zeidler, Reinhard ;
Lang, Stephan ;
Whiteside, Theresa L. .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2007, 56 (09) :1429-1442
[10]
Expansion of human T regulatory type 1 cells in the microenvironment of cyclooxygenase 2 overexpressing head and neck squamous cell carcinoma [J].
Bergmann, Christoph ;
Strauss, Laura ;
Zeidler, Reinhard ;
Lang, Stephan ;
Whiteside, Theresa L. .
CANCER RESEARCH, 2007, 67 (18) :8865-8873